Free-cash-flow proxy increased 9.6%
Free-cash-flow proxy changed +9.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$31.8M→-$28.7M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →VNDA financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow increased 10.1%
Operating cash flow changed +10.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-$31.6M→-$28.4M2 prior comparisons
Free-cash-flow margin moved 1533 bp higher
Free-cash-flow margin changed +1533 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-56.50%→-41.17%2 prior comparisons
Operating cash-flow margin moved 1549 bp higher
Operating cash-flow margin changed +1549 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
-56.22%→-40.73%2 prior comparisons
Receivables / revenue moved 344 bp lower
Receivables / revenue changed -344 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
89.84%→86.39%2 prior comparisons
Research & development increased 22.4%
Research & development changed +22.4% from the comparable as-filed period.
$22.6M→$27.6M2 prior comparisons
Trade receivables increased 19.3%
Trade receivables changed +19.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$50.5M→$60.3M4 prior comparisons
Capital expenditure increased 93.2%
Capital expenditure changed +93.2% from the comparable as-filed period.
$161,000→$311,0002 prior comparisons
Cash & equivalents decreased 11.6%
Cash & equivalents changed -11.6% from the comparable as-filed period.
$70.0M→$61.9M3 prior comparisons
Inventory decreased 25.2%
Inventory changed -25.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.0M→$1.5M4 prior comparisons
Inventory / revenue moved 144 bp lower
Inventory / revenue changed -144 basis points from the comparable as-filed period.
3.63%→2.19%2 prior comparisons
Capex / revenue moved 16 bp higher
Capex / revenue changed +16 basis points from the comparable as-filed period.
0.29%→0.45%2 prior comparisons
Stock-based compensation increased 10.7%
Stock-based compensation changed +10.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.1M→$2.3M2 prior comparisons
SBC / revenue moved 40 bp lower
SBC / revenue changed -40 basis points from the comparable as-filed period.
3.75%→3.35%2 prior comparisons
Selling, general & administrative decreased 1.2%
Selling, general & administrative changed -1.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$60.3M→$59.6M2 prior comparisons
R&D / revenue moved 54 bp lower
R&D / revenue changed -54 basis points from the comparable as-filed period.
40.11%→39.56%2 prior comparisons
Free-cash-flow margin moved 3230 bp lower
Free-cash-flow margin changed -3230 basis points from the comparable as-filed period.
-29.57%→-61.87%2 prior comparisons
Operating cash-flow margin moved 3249 bp lower
Operating cash-flow margin changed -3249 basis points from the comparable as-filed period.
-29.00%→-61.49%2 prior comparisons
Receivables / revenue moved 3258 bp higher
Receivables / revenue changed +3258 basis points from the comparable as-filed period.
85.55%→118.13%2 prior comparisons
Revenue decreased 3.9%
Revenue changed -3.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$52.6M→$50.5M2 prior comparisons
Capital expenditure decreased 36.5%
Capital expenditure changed -36.5% from the comparable as-filed period.
$299,000→$190,0003 prior comparisons
R&D / revenue moved 3132 bp higher
R&D / revenue changed +3132 basis points from the comparable as-filed period.
41.81%→73.13%2 prior comparisons
Selling, general & administrative increased 11.2%
Selling, general & administrative changed +11.2% from the comparable as-filed period.
$64.6M→$71.8M2 prior comparisons
Inventory decreased 22.6%
Inventory changed -22.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.2M→$1.7M4 prior comparisons
Capex / revenue moved 19 bp lower
Capex / revenue changed -19 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.57%→0.38%2 prior comparisons
Inventory / revenue moved 80 bp lower
Inventory / revenue changed -80 basis points from the comparable as-filed period.
4.12%→3.32%2 prior comparisons
SBC / revenue moved 17 bp higher
SBC / revenue changed +17 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
4.00%→4.17%2 prior comparisons
Stock-based compensation increased 0.0%
Stock-based compensation changed +0.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$2.1M→$2.1M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.